Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: : can we make better use of patient data registries?

Thomas Edward Patton; Laura Bojke; Matthew James Walton; Andrea Manca; Philip Helliwell

doi:10.1007/s10067-017-3703-9

Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: : can we make better use of patient data registries?

Thomas Edward Patton, Laura Bojke, Matthew James Walton, Andrea Manca, Philip Helliwell

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	8
Journal	Clinical rheumatology
DOIs	https://doi.org/10.1007/s10067-017-3703-9
Publication status	Published - 13 Jun 2017

Bibliographical note

Access to Document

10.1007/s10067-017-3703-9

Patton_et_al-2017-Clinical_Rheumatology
© The Authors 2017.
Final published version, 442 KBLicence: CC BY

Cite this

@article{af2c81cd843649d3b65fb5958de94db2,

title = "Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: : can we make better use of patient data registries?",

author = "Patton, {Thomas Edward} and Laura Bojke and Walton, {Matthew James} and Andrea Manca and Philip Helliwell",

note = "{\textcopyright} The Author(s) 2017. ",

year = "2017",

month = jun,

day = "13",

doi = "10.1007/s10067-017-3703-9",

language = "English",

journal = "Clinical rheumatology",